3rd Synthetic Biology Based Therapeutics Summit

As biotech propels forward, rewriting the very rules of biological systems for targeted, controlled, and safe therapeutic outcomes grows exponentially.

With advancements in DNA synthesis, tissue engineering, and the emergence of logic gating, the 3rd Synthetic Biology-Based Therapeutics Summit is a platform uniting academia, engineers, and drug developers working towards increased specificity, durability and potency.

Covering all the hottest applications from cell and gene therapy, mRNA based therapies and the microbiome with workshops, panels, case studies and clinical updates, this summit encapsulates the forefront of engineered biology.

Gain valuable insights on synthetic cytokines, gene circuitry, AI-driven protein design, enhanced gene engineering, and the groundbreaking world of engineered biology from our expert speaker faculty spanning the likes of Arsenal Bio, Synlogic, Senti Bio, Replay Bio, Gingko Bioworks, BMS, Merck, Kite Pharma, Johns Hopkins, MIT, Strand Therapeutics, and more.

As the divide between academia and industry narrows, this summit acts as a bridge, fostering collaboration and partnerships that can drive your platform or drug development strategy forward.